Get Premium to unlock powerful stock data
NAS:ENTX (Israel)  
Entera Bio Ltd logo

Entera Bio Ltd

$ 1.62 +0.01 (+0.62%) 10:08 PM EST
P/E:
At Loss
P/B:
2.36
Market Cap:
$ 46.67M
Enterprise V:
$ 26.80M
Volume:
45.56K
Avg Vol (2M):
31.80K
Also Trade In:
Volume:
45.56K
Market Cap $:
46.67M
PE Ratio:
At Loss
Avg Vol (2-Month):
31.80K
Enterprise Value $:
26.80M
PB Ratio:
2.36
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Entera Bio Ltd
SIC : 2836
Minrav Building - Fifth Floor, Kiryat Hadassah, Jerusalem Bio Park, Jerusalem, ISR, 9112002
Description
Entera Bio Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for use in areas with significant unmet medical need and where adoption of injectable therapies is limited due to cost, convenience and compliance challenges for patients. The company's product candidates, EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are in clinical development. The company recently completed the phase 2 study for EB613. The company also licenses its technology to biopharmaceutical companies for use with their proprietary compounds and, to date, has established a collaboration with Amgen Inc.
Name Current Vs Industry Vs History
Cash-To-Debt 83.79
Equity-to-Asset 0.89
Debt-to-Equity 0.01
Debt-to-EBITDA -0.02
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.59
Distress
Grey
Safe
Beneish M-Score 10.91
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.46
9-Day RSI 32.28
14-Day RSI 34.86
6-1 Month Momentum % -28.52
12-1 Month Momentum % -64.32

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.27
Quick Ratio 9.27
Cash Ratio 8.62
Days Sales Outstanding 117.53
Days Payable 280.72

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -36

Financials (Next Earnings Date:2022-08-16 Est.)

ENTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ENTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.482
EPS (TTM) ($) -0.22
Beta 1.31
Volatility % 105.77
14-Day RSI 34.86
14-Day ATR ($) 0.189273
20-Day SMA ($) 1.889
12-1 Month Momentum % -64.32
52-Week Range ($) 1.43 - 6.6
Shares Outstanding (Mil) 28.81

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Entera Bio Ltd Filings

Document Form Filing Date
No Filing Data

Headlines

See More